Skip to main content

Find Clinical Trials

Home
Conditions
Surgical Site Infection

Clinical trial condition

Surgical Site Infection

Explore clinical trials studying Surgical Site Infection. Study availability and eligibility vary by location and protocol.

221 public trials 26 recruiting studies

Refine in advanced search Browse all conditions

Surgical Site Infection trial results

Completed

Study to Evaluate DACC Dressings for the Prevention of Surgical Site Infections in Women Undergoing Caesarean Section.

NCT02168023

Conditions: Infection; Cesarean Section, Infections, Pathologic Processes, +5 more
Locations: Chair and Department of Obstetrics and Gynecology, II Faculty of Medicine, Medical University of Warsaw Warsaw, Masovian Voivodeship, Poland

View Trial Details

Completed

Safety Study to Evaluate the Contact Sensitizing Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

NCT02160587

Conditions: Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +4 more
Locations: BioScience Laboratories, Inc. Bozeman, Montana, United States

View Trial Details

Completed

Safety Study to Evaluate the Cumulative Irritation Potential of Topically Applied ZuraPrep™ and ZuraPrep™ Without IPA

NCT02160574

Conditions: Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +4 more
Locations: BioScience Laboratories Bozeman, Montana, United States

View Trial Details

Completed

Use of a Microbial Sealant to Reduce Surgical Site Infections.

NCT02241915

Conditions: Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +5 more
Locations: Los Angeles County/USC Medical Center Los Angeles, California, United States

View Trial Details

Completed

DFA-02 in Patients Undergoing Colorectal Surgery

NCT01496352

Conditions: Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Florence, Alabama, United States

Tampa, Florida, United States

Columbus, Ohio, United States

Bellaire, Texas, United States

View Trial Details

Completed

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT01431339

Conditions: Abscess, Cellulitis, Connective Tissue Diseases, +11 more
Locations: Durata Clinical Site Montgomery, Alabama, United States

Durata Clinical Site Anaheim, California, United States

Durata Clinical Site Buena Park, California, United States

Durata Study Site Chula Vista, California, United States

View all 137 locations

View Trial Details

Completed

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT01339091

Conditions: Abscess, Cellulitis, Connective Tissue Diseases, +11 more
Locations: Durata Study Site Anaheim, California, United States

Durata Study Site Azusa, California, United States

Durata Study Site Bellflower, California, United States

Durata Study Site Buena Park, California, United States

View all 91 locations

View Trial Details

Completed

Effect of Triclosan-coated Suture on Superficial SSI

NCT02018289

Conditions: Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +6 more
Locations: General University Hospital Elche Elche, Alicante, Spain

View Trial Details

Completed

A Comparison of Infection Rates Between Two Surgical Sites

NCT01263262

Conditions: Chemically-Induced Disorders, Corneal Toxicity, Drug-Related Side Effects and Adverse Reactions, +12 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Completed

Wound Infection in Obese Women After Cesarean Delivery

NCT01679379

Conditions: Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +4 more
Locations: Ain shams university Cairo, Egypt

View Trial Details